Showing results (181-190 of 565) with videos related to
Sort By:
Pageof 57
Steroids|June 10, 1998
Etiology of anovulation in polycystic ovary syndromeS Franks, H Mason, D White, et al.The Journal of Endocrinology|October 1, 1988
Inhibition of phospholipase A2 isoenzymes in human endometrium by mefenamic acid and indomethacin: modulation by calcium ionsR C Bonney, S T Qizilbash, S FranksClinical Endocrinology|February 1, 1987
Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndromeD W Polson, H D Mason, S FranksClinics in Obstetrics and Gynaecology|September 1, 1985
Ovulatory disorders in women with polycystic ovary syndromeS Franks, J Adams, H Mason, et al.Human Reproduction (Oxford, England)|November 1, 1992
The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndromeR Homburg, C Pariente, B Lunenfeld, et al.Contraception|November 1, 1978
Failure of withdrawal bleeding during combined oral contraceptive therapy: "amenorrhoea on the pill"M D Gillmer, E J Fox, H S JacobsClinical Endocrinology|January 29, 2000
The prevalence of polycystic ovaries in women with type 2 diabetes mellitusJ J Conn, H S Jacobs, G S ConwayGynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|March 1, 1991
Combined growth hormone and gonadotropin treatment for ovulation induction in patients with non-responsive ovariesR Homburg, C West, H Ostergaard, et al.Clinical Endocrinology|May 1, 1990
A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemiaR Homburg, C West, J Brownell, et al.Current Opinion in Obstetrics & Gynecology|February 1, 1995
Balancing the risk of recurrent thromboembolism and pre-existing osteoporosis in pregnancyA Kyei-Mensah, S J Machin, H S JacobsPageof 57